The risks of taking benzodiazepines for more than 2 -4 weeks are finally getting attention in the press and through various new published articles.  TSRG is working with the Alliance for Benzodiazepine Best Practices (Dr. Alexis Ritvo and Bernie Silvernail), the Benzodiazepine Information Coalition (Dr. Christy Huff and Nicole Lamberson), Choices Recovery Training (Ginger Ross), the Colorado Consortium for Prescription Drug Abuse Prevention’s Benzodiazepine

Danielle Edwards, one of two TSRG interns in 2022, is assisting with the Rural Recovery Network project to investigate the availability of medication-assisted treatment (MAT) in 9 county’s criminal justice facilities in rural southern Colorado. This is part of a MAT expansion project through Colorado SB-21-137.  Danielle is conducting a literature review, transcribing audio, and video files, helping prepare a

For more than 4 years, a group of committed doctors, patients, and policy experts have been working to raise awareness about the risk of patients developing BIND (benzodiazepine-induced neurological dysfunction) when benzodiazepines are taken as prescribed for more than 2 – 4 weeks. Carrie Silvernail, RN, and Steve Wright, MD, have comprehensively summarized this risk and the importance of providers

MISSION STATEMENT Our mission is to improve outcomes associated with addiction-prone substances through community outreach and research. About Us The Schreiber Research Group (TSRG) is a research-driven organization that conducts research, performs community outreach, and provides consulting services to positively influence how communities, governments, policymakers, and providers make implementation choices regarding programs and services for addiction-prone substance prevention, treatment, and